SCHEMBL18954746

SCHEMBL18954746

CCOC(=O)CCN1C(=O)C(=O)c2cc(Br)cc(Br)c21

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PARK7 Q99497 4/20 0.52
ALDH1A1 P00352 6/20 0.47
MAPT P10636 3/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ALDH2 P05091 4/20 0.43
ALDH3A1 P30838 4/20 0.43
TP53 P04637 2/20 0.41
TNF P01375 2/20 0.40
KAT2B Q92831 1/20 0.40
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
PIN1 Q13526 1/20 0.38
PIN4 Q9Y237 1/20 0.38
CUL4A Q13619 1/20 0.38
CASP3 P42574 1/20 0.37
CASP7 P55210 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954759 0.93 PARK7 (0.50) PARK7ALDH1A1MAPTHTTHSD17B10
SCHEMBL9179332 0.87 ALDH1A1 (0.62) PARK7ALDH1A1MAPTHTTHSD17B10
SCHEMBL18954749 0.78 ALDH1A1 (0.57) ALDH1A1MAPTHTTHSD17B10ALDH3A1
SCHEMBL18954460 0.78 ALDH1A1 (0.47) ALDH1A1MAPTHTTHSD17B10ALDH2
SCHEMBL18954588 0.78 ALDH1A1 (0.53) ALDH1A1MAPTHTTHSD17B10TP53
SCHEMBL18955261 0.74 ALDH1A1 (0.58) PARK7ALDH1A1MAPTHTTHSD17B10
SCHEMBL18954792 0.73 PARK7 (0.44) PARK7ALDH1A1MAPTHTTHSD17B10
SCHEMBL18954539 0.73 ALDH1A1 (0.62) PARK7ALDH1A1MAPTHTTHSD17B10
SCHEMBL18954738 0.73 PARK7 (0.50) PARK7ALDH1A1MAPTHTTHSD17B10
SCHEMBL4737553 0.73 PARK7 (0.59) PARK7ALDH1A1MAPTALDH2ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 WO disclosed